Now About Six Years Out From When This Beyaz / Safyral / YAZ / Yasmin / Gianvi / Ocella Drug Injury Litigation Started, Bayer Continues Its Slow-Going Pace
(Posted by Tom Lamb at DrugInjuryWatch.com)
To put into context the latest YAZ / Yasmin lawsuits and settlement numbers from Bayer, we start by referring back to this earlier article, "YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, 'Additional lawsuits are anticipated.'", where we get this corporate filing information:
- As of January 31, 2015, the number of claimants in the pending lawsuits and claims in the United States totaled about 5,000 (excluding claims already settled).
- As of January 31, 2015, Bayer had reached agreements, without admission of liability, to settle approximately 9,500 claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) for a total amount of about US$1.9 billion.
- At present, about 2,000 such claims are under review....
_____________________________________________________
Beyaz/Safyral/YAZ/Yasmin/Ocella/Gianvi
Free Case Evaluation
Strictly Confidential, No Obligation.
_____________________________________________________
The most recent Bayer information about the YAZ / Yasmin litigation comes from the Bayer Interim Report for First Quarter of 2015 (at pg. 46 of PDF):
Yasmin™/yaz™: As of April 20, 2015, the number of claimants in the pending lawsuits and claims in the United States totaled about 4,600 (excluding claims already settled). Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or yaz™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and yaz™, respectively, marketed by Barr Laboratories, Inc. in the United States.
As of April 20, 2015, Bayer had reached agreements, without admission of liability, to settle approximately 9,600 claims in the u.s. for venous clot injuries (deep vein thrombosis or pulmonary embolism) for a total amount of about us$1.92 billion. Bayer will continue to consider the option of settling such claims after a case-specific analysis of medical records. At present, about 1,000 such claims are under review.
And so it goes, ever so slow....
We will continue to report periodically on the entire Beyaz / Safyral / YAZ / Yasmin / Gianvi / Ocella drug injury litigation, as we have been doing since 2009 when the first lawsuits against Bayer were filed.
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb)
Drug Injury Case Evaluation - Free & Confidential (Case review done by attorney Tom Lamb)